首页>
外国专利>
Angiogenesis inhibitory composition comprising an inhibitory compound and antiinflammatory drug
Angiogenesis inhibitory composition comprising an inhibitory compound and antiinflammatory drug
展开▼
机译:包含抑制化合物和抗炎药的血管生成抑制组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
A group of compounds that effectively inhibit angiogenesis is described. More specifically, the compounds comprise thalidomide or thalidomide precursors, analogues, metabolites and hydrolysis products, and antiinflammatory drugs, such as NSAIDs. The NSAIDs are selected from group consisting of aspirin, acetominophen, ibuprofen, esculetin, phenidone, quercetin, ketoprofen, nordihydroguiaretic acid (NDGA), sulindac, sulindac sulfone, sulindac sulfide, indomethacin, NS-398 (a cyclooxygenase-2 inhibitor), cyclooxygenase- 1 inhibitors, methylheptyl imidazole, furegrelate sodium, SKF525AHCL, thromboxane inhibitors, toradol, ecasa, salsalate, diflunisal, mefenamic acid, naproxen, naproxen sodium, floctafenine, meclofenamate, phenylbutazone, oxyphenbutazone, diclofenac, etodolac, fenoprofen, flufenamic acid, flurbiprofen, pirprofen, tolmetin, apazone, fenbufen, nabumetone, oxaprozin, piroxicam, salicylate, and tenoxicam. Importantly, these compounds can be administered orally.
展开▼